Welcome to Dividend.com
Please help us personalize your experience.
Select the one that best describes you

Virtus LifeSci Biotech Products ETF

etf
BBP
Dividend policy
Suspended
Price as of:
$ N/A 0
primary theme
Health Care Sector Equity
BBP (ETF)

Virtus LifeSci Biotech Products ETF

Dividend policy
Suspended
Price as of:
$ N/A 0
primary theme
Health Care Sector Equity
BBP (ETF)
Virtus LifeSci Biotech Products ETF
Dividend policy
Suspended
Price as of:
$ N/A 0
primary theme
Health Care Sector Equity

BBP - Snapshot

Vitals

  • YTD Return 18.5%
  • 3 Yr Annualized Return 7.1%
  • 5 Yr Annualized Return 9.9%
  • Net Assets $26.5 M
  • Holdings in Top 10 34.6%

52 WEEK LOW AND HIGH

N/A
N/A
N/A

Expenses

OPERATING RELATED FEES

  • Expense Ratio 0.79%

SALES FEES

  • Front Load N/A
  • Deferred Load N/A

BROKERAGE FEES

  • Turnover 41.00%

TRADING FEES

  • Max Redemption Fee N/A

Min Investment

  • Standard (Taxable) N/A
  • IRA N/A

Fund Classification

  • Primary Theme Health Care Sector Equity
  • Fund Type Exchange Traded Fund
  • Investment Style Health

Compare BBP to Popular Health Care Sector Equity Funds

Overview

Next Dividend

Income Profile

Income Risk

Returns Profile

Allocations

Expenses

About

Dividend.com Ratings*

$107.87

+0.39%

$12.74 B

1.19%

$1.27

blocked
blocked
blocked

12.42%

-

Compare BBP to Popular Health Care Sector Equity ETFs

Overview

Next Dividend

Income Profile

Income Risk

Returns Profile

Allocations

Expenses

About

Dividend.com Ratings*

$109.74

+0.27%

$22.44 B

1.50%

$1.65

blocked
blocked
blocked

8.64%

-

$215.66

+0.31%

$12.74 B

1.19%

$2.55

blocked
blocked
blocked

13.29%

-

$144.98

+1.23%

$8.76 B

0.21%

$0.30

blocked
blocked
blocked

20.59%

-

$313.21

+0.73%

$8.15 B

0.27%

$0.84

blocked
blocked
blocked

18.72%

-

$133.20

+1.32%

$5.33 B

0.08%

$0.11

blocked
blocked
blocked

39.77%

-

BBP - Profile

Distributions

  • YTD Total Return 18.5%
  • 3 Yr Annualized Total Return 7.1%
  • 5 Yr Annualized Total Return 9.9%
  • Capital Gain Distribution Frequency N/A
  • Net Income Ratio -0.51%
DIVIDENDS
  • Dividend Yield 0.0%
  • Dividend Distribution Frequency Annually

Fund Details

  • Legal Name
    Virtus LifeSci Biotech Products ETF
  • Fund Family Name
    Virtus
  • Inception Date
    Dec 16, 2014
  • Shares Outstanding
    550004
  • Share Class
    N/A
  • Currency
    USD
  • Domiciled Country
    United States
  • Manager
    Matthew Brown

Fund Description

Under normal market conditions, the fund will invest not less than 80% of its assets in component securities of the index. The index seeks to track the performance of the common stock of U.S. exchange-listed biotechnology companies with at least one drug therapy approved by the U.S. Food and Drug Administration ("FDA") for marketing.


BBP - Performance

Return Ranking - Trailing

Period BBP Return Category Return Low Category Return High Rank in Category (%)
YTD 18.5% -4.8% 143.7% 34.78%
1 Yr 27.3% -1.4% 132.6% 27.50%
3 Yr 7.1%* 0.8% 40.7% 87.41%
5 Yr 9.9%* -0.7% 29.6% 35.71%
10 Yr N/A* 8.1% 19.7% N/A

* Annualized

Return Ranking - Calendar

Period BBP Return Category Return Low Category Return High Rank in Category (%)
2019 24.7% 3.8% 63.8% 24.83%
2018 -14.0% -49.7% 21.5% 82.48%
2017 23.8% -59.8% 54.4% 25.93%
2016 6.3% -36.6% 11.6% 3.10%
2015 18.0% -62.4% 27.9% 2.46%

Total Return Ranking - Trailing

Period BBP Return Category Return Low Category Return High Rank in Category (%)
YTD 18.5% -4.8% 143.7% 34.78%
1 Yr 27.3% -6.5% 132.6% 23.75%
3 Yr 7.1%* -0.3% 40.7% 86.71%
5 Yr 9.9%* -0.7% 29.6% 34.29%
10 Yr N/A* 8.1% 19.7% N/A

* Annualized

Total Return Ranking - Calendar

Period BBP Return Category Return Low Category Return High Rank in Category (%)
2019 24.7% 3.8% 63.8% 24.83%
2018 -14.0% -25.3% 22.2% 83.94%
2017 23.8% -10.8% 54.4% 29.63%
2016 6.3% -36.6% 11.6% 3.88%
2015 18.0% -16.6% 27.9% 2.46%

BBP - Holdings

Concentration Analysis

BBP Category Low Category High BBP % Rank
Net Assets 26.5 M 3.74 M 46 B 85.47%
Number of Holdings 42 24 426 89.53%
Net Assets in Top 10 9.18 M 952 K 19.6 B 87.79%
Weighting of Top 10 34.60% 14.0% 75.7% 70.35%

Top 10 Holdings

  1. Immunomedics Inc 5.61%
  2. Sage Therapeutics Inc 4.86%
  3. BeiGene Ltd ADR 4.34%
  4. Aimmune Therapeutics Inc 3.93%
  5. Amicus Therapeutics Inc 3.91%
  6. Ultragenyx Pharmaceutical Inc 3.54%
  7. Blueprint Medicines Corp 3.51%
  8. Momenta Pharmaceuticals Inc 3.45%
  9. Retrophin Inc 3.17%
  10. Halozyme Therapeutics Inc 2.94%

Asset Allocation

Weighting Return Low Return High BBP % Rank
Stocks
98.69% 61.47% 102.50% 43.60%
Cash
1.31% -0.01% 32.46% 44.77%
Preferred Stocks
0.00% 0.00% 6.63% 50.58%
Other
0.00% -2.50% 6.07% 56.40%
Convertible Bonds
0.00% 0.00% 0.06% 41.28%
Bonds
0.00% 0.00% 16.11% 43.02%

Stock Sector Breakdown

Weighting Return Low Return High BBP % Rank
Healthcare
100.00% 61.81% 100.00% 14.53%
Utilities
0.00% 0.00% 0.00% 40.12%
Technology
0.00% 0.00% 15.86% 50.00%
Real Estate
0.00% 0.00% 6.03% 44.77%
Industrials
0.00% 0.00% 5.94% 45.35%
Financial Services
0.00% 0.00% 3.31% 63.37%
Energy
0.00% 0.00% 0.00% 40.12%
Communication Services
0.00% 0.00% 4.69% 43.02%
Consumer Defense
0.00% 0.00% 34.31% 45.35%
Consumer Cyclical
0.00% 0.00% 1.09% 43.60%
Basic Materials
0.00% 0.00% 2.60% 56.40%

Stock Geographic Breakdown

Weighting Return Low Return High BBP % Rank
US
94.35% 47.91% 99.98% 19.19%
Non US
4.34% 0.00% 43.79% 78.49%

BBP - Expenses

Operational Fees

BBP Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Expense Ratio 0.79% 0.08% 25.14% 66.87%
Management Fee 0.79% 0.00% 1.25% 70.35%
12b-1 Fee N/A 0.00% 1.00% N/A
Administrative Fee N/A 0.03% 0.40% N/A

Sales Fees

BBP Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Front Load N/A 3.50% 5.75% N/A
Deferred Load N/A 1.00% 5.00% N/A

Trading Fees

BBP Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Max Redemption Fee N/A 1.00% 2.00% N/A

Related Fees

Turnover provides investors a proxy for the trading fees incurred by mutual fund managers who frequently adjust position allocations. Higher turnover means higher trading fees.

BBP Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Turnover 41.00% 0.70% 252.00% 61.35%

BBP - Distributions

Dividend Yield Analysis

BBP Category Low Category High BBP % Rank
Dividend Yield 0.00% 0.00% 3.15% 50.00%

Dividend Distribution Analysis

BBP Category Low Category High Category Mod
Dividend Distribution Frequency Annually Annually Semi-Annually Annually

Net Income Ratio Analysis

BBP Category Low Category High BBP % Rank
Net Income Ratio -0.51% -2.53% 2.53% 80.24%

Capital Gain Distribution Analysis

BBP Category Low Category High Capital Mode
Capital Gain Distribution Frequency Annually Semi-Annually Annually

Dividend Payout History

View More +

BBP - Fund Manager Analysis

Managers

Matthew Brown


Start Date

Tenure

Tenure Rank

Aug 14, 2017

3.22

3.2%

Matthew Brown serves as Portfolio Manager at Virtus ETF Advisers LL. Mr. Brown is also executive managing director and chief operating officer at Virtus ETF Solutions LLC (“VES”) since 2012. Before founding VES in 2012, he served as director of operations for Factor Advisors from 2010 to 2012. In 2009, Mr. Brown co-founded ETP Resources, a consulting and data services business that continues to grow and serve the ETF industry. From 2008 to 2009, he headed U.S. operations and served as chief compliance officer for U.K.-based issuer SPA/London & Capital. Mr. Brown earned a B.A. in Economics from Boston College.

Seth Kadushin


Start Date

Tenure

Tenure Rank

Aug 14, 2017

3.22

3.2%

Seth Kadushin serves as Portfolio Manager at Virtus ETF Advisers LLC. Mr. Kadushin has also served as director of capital markets at Virtus ETF Solutions LLC (“VES”) since 2013. Prior to joining VES, Mr. Kadushin worked at Euromoney Institutional Investor, Plc where he developed large scale investment management programs focusing on Exchange Traded Instruments and Alternate Investment Strategies. From 2011 through 2012 Mr. Kadushin worked at Wedbush Securities as an Options Desk Strategist. Mr. Kadushin worked at RBS Securities as Head Program Trader from 2009 through 2011. Prior to 2009, Mr. Kadushin held senior level positions at Lehman Brothers and Bear Sterns (J.P. Morgan), where he was a member of the firm’s Cross Asset Policy Committee charged with instituting their equity trading division’s guidelines. Mr. Kadushin holds a BBA in Finance from Emory University. He achieved his Master’s in Business from Fordham University with a concentration in Information Systems.

Tenure Analysis

Category Low Category High Category Average Category Mode
0.09 23.14 7.28 20.52

Continue to site >
Trending ETFs